Adult Congenital Heart Disease Registry (QuERI)
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Sponsor: Actelion
This observational or N/A phase trial investigates Pulmonary Arterial Hypertension and is currently completed. Actelion leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Mar 2025 — Present [monthly]
Completed
-
Sep 2024 — Mar 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 7 earlier versions
-
Jan 2019 — Feb 2019 [monthly]
Active Not Recruiting
-
Sep 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Actelion
- Canadian Heart Research Centre
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.